Edinburgh-based lender Royal Bank of Scotland Group plc said Monday that it had sold 95.1% of a share issue, or £11.6 billion ($22.9 billion) of stock, in an outcome seen as marking the rehabilitation of CEO Fred Goodwin.
Goodwin had shocked investors with news of the share sale in April,
having previously insisted the bank didn't need to raise new capital to
repair its balance sheet after writedowns and its consortium
acquisition of ABN Amro Bank NV.
Goldman Sachs Group Inc., Merrill Lynch & Co. and UBS AG are underwriters in the sale and will seek buyers for the remaining 299.4 million of shares, Royal Bank said. - Laura Board
Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.
Edinburgh-based lender Royal Bank of Scotland Group plc said Monday that it had sold 95.1% of a share issue, or £11.6 billion ($22.9 billion) of stock, in an outcome seen as marking the rehabilitation of CEO Fred Goodwin. 
